Work

Effects of pharmacological doses of 2-deoxyglucose on plasma catecholamines and glucose levels in patients with schizophrenia

Year: 2004

Type: article

Study design: Clinical Trial

Source: Psychopharmacology

DOI: 10.1007/s00213-004-1890-y

Authors: Igor Elman, David Rott, Alan I. Green, Daniel D. Langleben, Scott E. Lukas, David S. Goldstein, Alan Breier

Institutions: Harvard University, McLean Hospital, MedStar Heart & Vascular Institute, Dartmouth College, University of Pennsylvania, National Institute of Neurological Disorders and Stroke, Eli Lilly (United States)

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institute on Drug Abuse

Awards: G1705794022, G2619541672, Neuroimaging of Drug Craving in Cocaine Dependence

OpenAlex ID: W2156552033

FWCI: 0.83

Cites: 75

Cited by: 14

Related to: 10